The civic record
Read. Follow. Verify.Congressional Hearing on 340B Drug Pricing Program Improvements
Record date · January 1, 2019
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Does
The House Subcommittee on Health held a hearing on July 11, 2018, to examine potential improvements to the 340B Drug Pricing Program. The session included testimony from government accountability officials, hospital administrators, and pharmacy experts regarding the program's operations and oversight.
The allows certain hospitals and clinics to purchase outpatient drugs at discounted prices, and this hearing explored how federal oversight and program rules impact the availability and cost of these medications for patients and healthcare providers.
Who It Affects
Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.
Hospitals and Clinics
These entities participate in the 340B program to purchase discounted outpatient drugs.
Drug Manufacturers
These companies are required by law to provide drugs at specific discounted rates to eligible 340B entities.
Patients
Patients receiving care at 340B-eligible facilities may be impacted by how these facilities manage drug pricing and program participation.
Key Facts
- The hearing took place on July 11, 2018, in the Rayburn House Office Building.
- The hearing focused on identifying opportunities to improve the 340B Drug Pricing Program.
- Testimony was provided by representatives from the U.S. Government Accountability Office, Texas Oncology, Parkland Hospital, and the University of California, San Diego.
- Numerous organizations submitted written statements, including the Association of American Medical Colleges, 340B Health, and the Children's Hospital Association.
Show all 5 facts
- The Community Oncology Alliance submitted an article regarding alleged abuse of the 340B program.
Frequently Asked Questions
What is the 340B Drug Pricing Program?
Who testified at this hearing?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceFull breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Focus on Program Oversight
The hearing highlights a shift toward increased scrutiny of the 340B program's operational integrity and potential for abuse.
Connected Entities
Sources
www.govinfo.gov
Analysis Score
0–100- Significance75How much this matters to a regular citizen
- Controversy65Intensity of disagreement among stakeholders
- Entertainment10Compellingness for a non-policy-wonk reader
- Buzz20Current news / social attention level
Publisher tools